Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine

Since the beginning of the COVID-19 pandemic, efforts have been made to design safe and effective vaccines against SARS-CoV-2. Numerous vaccines have been designed and tested in limited clinical trials in various countries. Among them, the Sputnik V vaccine has shown a relatively safe profile and, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ameri, Maryam, Abolmaali, Meysam, Alwedaie, Sayed Mohammed Jawad, Nabavi, Mohammad, Rahimian, Neda, Hamidabad, Negin Mahmoodi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833308/
https://www.ncbi.nlm.nih.gov/pubmed/35169571
http://dx.doi.org/10.12890/2022_003042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833308/
https://www.ncbi.nlm.nih.gov/pubmed/35169571
http://dx.doi.org/10.12890/2022_003042

Ejemplares similares